The Role of Rifaximin in the Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Patients With Liver Cirrhosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Role of Rifaximin in the Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Patients With Liver Cirrhosis

Published:2012-09 Issue:8 Volume:46 Page:709-715
ISSN:0192-0790
Container-title:Journal of Clinical Gastroenterology
language:en
Short-container-title:

Author:

Hanouneh Mohamad A.,Hanouneh Ibrahim A.,Hashash Jana G.,Law Ryan,Esfeh Jamak Modaresi,Lopez Rocio,Hazratjee Nyla,Smith Thomas,Zein Nizar N.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology

Reference39 articles.

1. Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime.;Toledo;Hepatology,1993

2. Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis: a randomized controlled study of 100 patients.;Runyon;Gastroenterology,1991

3. Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study.;Rimola;Hepatology,1995

4. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections.;Felisart;Hepatology,1985

5. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis.;Navasa;Gastroenterology,1996

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Rifaximin Alone and With Quinolones in the Primary Prevention of Spontaneous Bacterial Peritonitis in Patients With Decompensated Chronic Liver Disease;Cureus;2024-02-29

2. Liver cirrhosis and complications from the perspective of dysbiosis;Frontiers in Medicine;2024-01-16

3. Impact of rifaximin use in infections and mortality in patients with decompensated cirrhosis and hepatic encephalopathy;Therapeutic Advances in Gastroenterology;2024-01

4. Rifaximin Reduces Risk of All-Cause Hospitalization in Cirrhotic Liver Transplant Candidates with Hepatic Encephalopathy;Journal of Clinical Medicine;2023-10-31

5. Antibiotics in Chronic Liver Disease and Their Effects on Gut Microbiota;Antibiotics;2023-09-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3